Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts

Research on the effectiveness of pharmacotherapies for schizophrenia and comorbid substance use disorder (SUD) is very sparse, and non-existent on the prevention of the development of SUDs in patients with schizophrenia. To compare the real-world effectiveness of antipsychotics in schizophrenia in d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of psychiatry 2022-12, Vol.221 (6), p.758-765
Hauptverfasser:	Lähteenvuo, Markku, Luykx, Jurjen J., Taipale, Heidi, Mittendorfer-Rutz, Ellenor, Tanskanen, Antti, Batalla, Albert, Tiihonen, Jari
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - therapeutic use Antipsychotics Chronic Disease Clinical trials Clozapine Clozapine - therapeutic use Codes Comorbidity Disability pensions Drug use General Adult Hospitalization Humans Medicin och hälsovetenskap Mental disorders Mortality Patient admissions Patients Prescription drugs Psychiatry Psychosis Psychotropic drugs Recurrence Regression analysis Relapse Schizophrenia Schizophrenia - drug therapy Schizophrenia - epidemiology Substance use Substance use disorder Substance-Related Disorders - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!